查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1585682

禽流感治療市場：按類型、最終用戶分類 - 2025-2030 年全球預測

Bird Flu Treatment Market by Type (Antivirals, Combination Treatment, Prophylactic Antibiotics), End-User (Clinics, Hospital, Institutional Health Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年禽流感治療市場規模為220.6億美元，預計2024年將達到238.5億美元，複合年成長率為8.18%，預計到2030年將達到382.7億美元。

禽流感治療市場包括頻譜旨在管理和潛在治癒禽流感的產品和服務，禽流感是一種對家禽業和公共衛生都有重大影響的病毒性疾病。這個市場的推動是為了控制禽流感的爆發，禽流感影響家禽業，並且可以跨物種傳染給人類，因此需要提供預防性疫苗和抗病毒治療。禽流感治療的應用範圍包括動物用藥品、人類保健和農業環境中的生態系統管理。最終用戶包括家禽養殖戶、醫療保健提供者、政府以及參與糧食安全和疾病預防的組織。影響市場的主要成長要素包括由於遷徙模式導致禽流感爆發頻率增加、消費者對通用感染疾病的認知不斷提高以及疫苗和治療方法開發的進步。該市場的機會在於增強的監測技術、增強的生物安全措施以及擴大頻譜抗病毒藥物的可用性。政府和組織可以透過投資更有效的疫苗研發以及建立公私夥伴關係來簡化應對策略，從而利用這些機會。然而，挑戰依然存在，包括疫苗開發相關的高成本、大規模免疫宣傳活動的物流、監管障礙以及病毒快速變異導致疫苗抗藥性的能力。由於新興國家獲得有效治療方法的機會有限，市場情勢進一步複雜化。創新可以集中在 mRNA 疫苗平台、人工智慧驅動的流行病預測模型和改進的抗病毒配方上。促進跨部門合作還可以促進預防和管理疫情的全面解決方案。市場動態是動態的，其特點是對創新解決方案的迫切需求和嚴格的監管要求。長期永續性取決於風險評估、敏捷應變計畫以及對創新技術和全球合作的持續投資。

主要市場統計
基準年[2023] 220.6億美元
預測年份 [2024] 238.5億美元
預測年份 [2030] 382.7億美元
複合年成長率（%） 8.18%

市場動態：快速發展的禽流感治療市場的關鍵市場洞察

供需的動態交互作用正在改變禽流感治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 禽流感和其他通用感染疾病的盛行率增加
    • 提高大眾對禽流感的認知
    • 政府不斷採取措施開發更好的治療方法
  • 市場限制因素
    • 病毒對現有抗病毒藥物產生抗藥性以及與藥物開發相關的高成本
  • 市場機會
    • 新產品開發新投資
    • 禽流感治療藥物臨床試驗正在進行中
  • 市場挑戰
    • 嚴格的法規和核准流程

波特五力：駕馭禽流感治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解禽流感治療市場的外部影響

外部宏觀環境因素對禽流感治療市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解禽流感治療市場的競爭狀況

對禽流感治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 禽流感治療市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估禽流感治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪禽流感治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，禽流感治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 禽流感和其他通用感染疾病的盛行率增加
      • 大眾對禽流感的認知有所提高
      • 政府不斷努力開發更好的治療方法
    • 抑制因素
      • 病毒對現有抗病毒藥物產生抗藥性以及與藥物開發相關的高成本
    • 機會
      • 新產品開發新投資
      • 治療禽流感的臨床試驗正在進行中
    • 任務
      • 嚴格的法規和核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章禽流感治療市場：依類型

  • 抗病毒藥物
  • 合併治療
  • 預防性抗生素
  • Ribavirin

第7章禽流感治療市場：依最終使用者分類

  • 診所
  • 醫院
  • 設施健康中心

第8章北美和南美禽流感治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太禽流感治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲禽流感治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO SpA
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.
Product Code: MRR-CA17E905EAFA

The Bird Flu Treatment Market was valued at USD 22.06 billion in 2023, expected to reach USD 23.85 billion in 2024, and is projected to grow at a CAGR of 8.18%, to USD 38.27 billion by 2030.

The bird flu treatment market encompasses the spectrum of products and services aimed at managing and potentially curing avian influenza, a viral disease significantly impacting both poultry industries and public health. This market is driven by the necessity to control outbreaks that affect poultry farming and can cross species to humans, necessitating both preventive vaccines and antiviral therapeutics. Applications of bird flu treatments extend to veterinary pharmaceuticals, human healthcare, and ecosystem management within agricultural settings. End users include poultry farmers, healthcare providers, governments, and organizations involved in food security and disease prevention. Key growth factors influencing the market include the increasing frequency of bird flu outbreaks due to migratory patterns, rising consumer awareness about zoonotic diseases, and advancements in vaccine and therapeutic development. Opportunities within this market lie in enhancing surveillance technologies, strengthening biosecurity measures, and expanding the availability of broad-spectrum antivirals. Governments and organizations can capitalize on these opportunities by investing in R&D for more efficient vaccines and creating partnerships between the public and private sectors to streamline response strategies. However, challenges persist, including high costs associated with vaccine development, logistics of mass immunization campaigns, regulatory hurdles, and the virus's capacity for rapid mutation leading to vaccine resistance. Limited access to effective treatments in developing countries further complicates the market landscape. Innovations could focus on mRNA vaccine platforms, AI-driven outbreak prediction models, and improving antiviral formulations. Encouraging cross-sector collaboration could also facilitate comprehensive solutions to prevent and manage outbreaks. The market for bird flu treatment is dynamic, characterized by urgent demand for innovative solutions and stringent regulatory requirements. Long-term sustainability will depend on risk assessment, agile response planning, and continual investment in innovative technologies and cooperative global initiatives.

KEY MARKET STATISTICS
Base Year [2023] USD 22.06 billion
Estimated Year [2024] USD 23.85 billion
Forecast Year [2030] USD 38.27 billion
CAGR (%) 8.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bird Flu Treatment Market

The Bird Flu Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of avian influenza and other zoonotic diseases
    • Growing awareness of bird flu among population
    • Rising government initiatives to develop better therapeutics
  • Market Restraints
    • Resistance of the virus to existing antiviral drugs and high costs associated with therapeutics development
  • Market Opportunities
    • Emerging investment for novel product development
    • Ongoing clinical trials for bird flu treatments
  • Market Challenges
    • Stringent regulatory and approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Bird Flu Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bird Flu Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bird Flu Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bird Flu Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bird Flu Treatment Market

A detailed market share analysis in the Bird Flu Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bird Flu Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bird Flu Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bird Flu Treatment Market

A strategic analysis of the Bird Flu Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bird Flu Treatment Market, highlighting leading vendors and their innovative profiles. These include Alltech, Inc., BioCryst Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cipla Limited, CSL Limited, F. Hoffmann-La Roche Ltd., FATRO S.p.A., Gilead Sciences, Inc., GlaxoSmithKline PLC, Hester Biosciences Limited, Johnson & Johnson Services, Inc., Macleods Pharmaceuticals Ltd, Merck KGaA, Moderna, Inc., Novartis AG, PetSmart LLC, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited, Tianjin Ringpu Biotechnology Co. Ltd., Yebio Bioengineering Co. Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bird Flu Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antivirals, Combination Treatment, Prophylactic Antibiotics, and Ribavirin.
  • Based on End-User, market is studied across Clinics, Hospital, and Institutional Health Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of avian influenza and other zoonotic diseases
      • 5.1.1.2. Growing awareness of bird flu among population
      • 5.1.1.3. Rising government initiatives to develop better therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Resistance of the virus to existing antiviral drugs and high costs associated with therapeutics development
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging investment for novel product development
      • 5.1.3.2. Ongoing clinical trials for bird flu treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory and approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bird Flu Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Antivirals
  • 6.3. Combination Treatment
  • 6.4. Prophylactic Antibiotics
  • 6.5. Ribavirin

7. Bird Flu Treatment Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospital
  • 7.4. Institutional Health Centers

8. Americas Bird Flu Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bird Flu Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bird Flu Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech, Inc.
  • 2. BioCryst Pharmaceuticals, Inc.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Ceva Sante Animale
  • 5. Cipla Limited
  • 6. CSL Limited
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. FATRO S.p.A.
  • 9. Gilead Sciences, Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Hester Biosciences Limited
  • 12. Johnson & Johnson Services, Inc.
  • 13. Macleods Pharmaceuticals Ltd
  • 14. Merck KGaA
  • 15. Moderna, Inc.
  • 16. Novartis AG
  • 17. PetSmart LLC
  • 18. Pfizer Inc.
  • 19. Sanofi S.A.
  • 20. Serum Institute of India Pvt. Ltd.
  • 21. Sinovac Biotech Ltd.
  • 22. Takeda Pharmaceutical Company Limited
  • 23. Tianjin Ringpu Biotechnology Co. Ltd.
  • 24. Yebio Bioengineering Co. Ltd.
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. BIRD FLU TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BIRD FLU TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIRD FLU TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PROPHYLACTIC ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RIBAVIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INSTITUTIONAL HEALTH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023